Q2 2026 Holdings
Filed 2026-08-14 | 84 holdings | $11.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $1.1B | 1,993,687 | 9.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $658.2M | 709,446 | 5.6% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $631.9M | 7,746,415 | 5.4% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $620.4M | 5,061,175 | 5.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $605.0M | 8,514,590 | 5.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $516.3M | 4,842,880 | 4.4% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $434.5M | 13,900,620 | 3.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $377.5M | 4,251,996 | 3.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $345.8M | 3,304,903 | 3.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $328.8M | 17,946,754 | 2.8% |
| Radnet Inc(RDNT) | COM | 750491102 | $298.9M | 4,846,958 | 2.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $298.7M | 3,139,030 | 2.6% |
| Natera Inc(NTRA) | COM | 632307104 | $271.5M | 1,000,000 | 2.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $260.3M | 7,796,895 | 2.2% |
| Irhythm Holdings Inc(IRTC) | COM | 450056106 | $259.6M | 2,182,631 | 2.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $243.8M | 2,862,003 | 2.1% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $237.4M | 10,776,820 | 2.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $227.9M | 2,655,695 | 1.9% |
| Guardant Health Inc(GH) | COM | 40131M109 | $222.2M | 1,481,033 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $213.7M | 1,267,925 | 1.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $211.3M | 3,357,059 | 1.8% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $184.0M | 5,623,525 | 1.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $181.5M | 3,941,572 | 1.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $180.8M | 7,144,524 | 1.5% |
| Repligen Corp(RGEN) | COM | 759916109 | $169.3M | 1,240,637 | 1.4% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $167.2M | 4,543,895 | 1.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $159.5M | 5,933,815 | 1.4% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $154.6M | 4,869,798 | 1.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $151.4M | 10,700,974 | 1.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $131.1M | 12,946,176 | 1.1% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $124.9M | 6,574,032 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $122.4M | 3,177,849 | 1.0% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $110.2M | 715,332 | 0.9% |
| Xencor Inc(XNCR) | COM | 98401F105 | $109.1M | 6,777,461 | 0.9% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $92.3M | 13,560,258 | 0.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $89.4M | 2,309,021 | 0.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $87.6M | 1,672,356 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $86.3M | 1,607,507 | 0.7% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $82.0M | 7,411,581 | 0.7% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $66.3M | 2,778,335 | 0.6% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $66.1M | 6,422,018 | 0.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $60.5M | 17,687,772 | 0.5% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $58.0M | 1,487,934 | 0.5% |
| Aktis Oncology Inc(AKTS) | COM | 01021M104 | $51.3M | 1,592,043 | 0.4% |
| Axogen Inc(AXGN) | COM | 05463X106 | $46.7M | 1,011,576 | 0.4% |
| Danaher Corp del(DHR) | COM | 235851102 | $43.8M | 230,000 | 0.4% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $43.1M | 2,364,347 | 0.4% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $42.8M | 1,362,456 | 0.4% |
| Hinge Health Inc(HNGE) | CL A | 433313103 | $41.5M | 500,000 | 0.4% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $41.2M | 9,556,063 | 0.4% |